> top > docs > PMC:2065877 > spans > 141-1023 > annotations

PMC:2065877 / 141-1023 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T89 0-6 JJ denotes Latent
T90 7-15 NN denotes membrane
T91 16-23 NN denotes protein
T92 24-25 CD denotes 1
T93 26-27 -LRB- denotes (
T94 27-31 NN denotes LMP1
T95 31-32 -RRB- denotes )
T96 33-35 VB denotes is
T97 36-39 DT denotes the
T98 40-45 JJ denotes major
T99 46-57 NN denotes oncoprotein
T100 58-60 IN denotes of
T101 61-73 JJ denotes Epstein-Barr
T102 74-79 NN denotes virus
T103 80-81 -LRB- denotes (
T104 81-84 NN denotes EBV
T105 84-85 -RRB- denotes )
T106 87-89 IN denotes In
T107 90-100 JJ denotes transgenic
T108 101-105 NN denotes mice
T109 105-106 -COMMA- denotes ,
T110 107-111 NN denotes LMP1
T111 112-120 VB denotes promotes
T112 121-130 VB denotes increased
T113 131-139 NN denotes lymphoma
T114 140-151 NN denotes development
T115 152-154 IN denotes by
T116 155-157 CD denotes 12
T117 158-160 NN denotes mo
T118 161-163 IN denotes of
T119 164-167 NN denotes age
T120 169-173 DT denotes This
T121 174-179 NN denotes study
T122 180-187 VB denotes reveals
T123 188-192 IN denotes that
T124 193-201 NN denotes lymphoma
T125 202-210 VB denotes develops
T126 211-213 IN denotes in
T127 214-218 NN denotes B-1a
T128 219-230 NN denotes lymphocytes
T129 230-231 -COMMA- denotes ,
T130 232-233 DT denotes a
T131 234-244 NN denotes population
T132 245-249 WDT denotes that
T133 250-252 VB denotes is
T134 253-263 VB denotes associated
T135 264-268 IN denotes with
T136 269-283 NN denotes transformation
T137 284-286 IN denotes in
T138 287-292 JJ denotes older
T139 293-297 NN denotes mice
T140 299-302 DT denotes The
T141 303-311 NN denotes lymphoma
T142 312-317 NN denotes cells
T143 318-322 VB denotes have
T144 323-334 VB denotes deregulated
T145 335-339 NN denotes cell
T146 340-345 NN denotes cycle
T147 346-353 NN denotes markers
T148 353-354 -COMMA- denotes ,
T149 355-358 CC denotes and
T150 359-369 NN denotes inhibitors
T151 370-372 IN denotes of
T152 373-376 NN denotes Akt
T153 376-377 -COMMA- denotes ,
T154 378-382 NN denotes NFκB
T155 382-383 -COMMA- denotes ,
T156 384-387 CC denotes and
T157 388-393 NN denotes Stat3
T158 394-399 VB denotes block
T159 400-403 DT denotes the
T160 404-412 VB denotes enhanced
T161 413-422 NN denotes viability
T162 423-425 IN denotes of
T163 426-430 NN denotes LMP1
T164 431-441 JJ denotes transgenic
T165 442-453 NN denotes lymphocytes
T166 454-457 CC denotes and
T167 458-466 NN denotes lymphoma
T168 467-472 NN denotes cells
T169 473-475 FW denotes in
T170 476-481 FW denotes vitro
T171 483-491 NN denotes Lymphoma
T172 492-497 NN denotes cells
T173 498-501 VB denotes are
T174 502-513 JJ denotes independent
T175 514-516 IN denotes of
T176 517-526 NN denotes IL4/Stat6
T177 527-536 NN denotes signaling
T178 537-540 IN denotes for
T179 541-549 NN denotes survival
T180 550-553 CC denotes and
T181 554-567 NN denotes proliferation
T182 567-568 -COMMA- denotes ,
T183 569-572 CC denotes but
T184 573-577 VB denotes have
T185 578-592 RB denotes constitutively
T186 593-602 VB denotes activated
T187 603-608 NN denotes Stat3
T188 609-618 NN denotes signaling
T189 620-625 DT denotes These
T190 626-630 JJ denotes same
T191 631-638 NN denotes targets
T192 639-642 VB denotes are
T193 643-647 RB denotes also
T194 648-659 VB denotes deregulated
T195 660-662 IN denotes in
T196 663-672 JJ denotes wild-type
T197 673-677 NN denotes B-1a
T198 678-687 NN denotes lymphomas
T199 688-692 WDT denotes that
T200 693-698 VB denotes arise
T201 699-712 RB denotes spontaneously
T202 713-720 IN denotes through
T203 721-724 NN denotes age
T204 725-739 NN denotes predisposition
T205 741-746 DT denotes These
T206 747-754 NN denotes results
T207 755-762 VB denotes suggest
T208 763-767 IN denotes that
T209 768-771 NN denotes Akt
T210 771-772 -COMMA- denotes ,
T211 773-777 NN denotes NFκB
T212 777-778 -COMMA- denotes ,
T213 779-782 CC denotes and
T214 783-788 NN denotes Stat3
T215 789-797 NN denotes pathways
T216 798-801 MD denotes may
T217 802-807 VB denotes serve
T218 808-810 IN denotes as
T219 811-820 JJ denotes effective
T220 821-828 NN denotes targets
T221 829-831 IN denotes in
T222 832-835 DT denotes the
T223 836-845 NN denotes treatment
T224 846-848 IN denotes of
T225 849-863 JJ denotes EBV-associated
T226 864-865 NN denotes B
T227 866-870 NN denotes cell
T228 871-880 NN denotes lymphomas
R27 T91 T89 arg1Of protein,Latent
R28 T91 T90 arg1Of protein,membrane
R29 T91 T92 arg1Of protein,1
R30 T91 T93 arg1Of protein,(
R31 T91 T96 arg1Of protein,is
R32 T94 T93 arg2Of LMP1,(
R33 T95 T93 arg3Of ),(
R34 T99 T96 arg2Of oncoprotein,is
R35 T99 T97 arg1Of oncoprotein,the
R36 T99 T98 arg1Of oncoprotein,major
R37 T99 T100 arg1Of oncoprotein,of
R38 T102 T100 arg2Of virus,of
R39 T102 T101 arg1Of virus,Epstein-Barr
R40 T102 T103 arg1Of virus,(
R41 T104 T103 arg2Of EBV,(
R42 T105 T103 arg3Of ),(
R43 T108 T106 arg2Of mice,In
R44 T108 T107 arg1Of mice,transgenic
R45 T110 T111 arg1Of LMP1,promotes
R46 T111 T106 arg1Of promotes,In
R47 T111 T109 arg1Of promotes,","
R48 T111 T115 arg1Of promotes,by
R49 T114 T111 arg2Of development,promotes
R50 T114 T112 arg2Of development,increased
R51 T114 T113 arg1Of development,lymphoma
R52 T117 T115 arg2Of mo,by
R53 T117 T116 arg1Of mo,12
R54 T117 T118 arg1Of mo,of
R55 T119 T118 arg2Of age,of
R56 T121 T120 arg1Of study,This
R57 T121 T122 arg1Of study,reveals
R58 T124 T125 arg1Of lymphoma,develops
R59 T125 T122 arg2Of develops,reveals
R60 T125 T123 arg1Of develops,that
R61 T125 T126 arg1Of develops,in
R62 T128 T126 arg2Of lymphocytes,in
R63 T128 T127 arg1Of lymphocytes,B-1a
R64 T128 T129 arg1Of lymphocytes,","
R65 T131 T129 arg2Of population,","
R66 T131 T130 arg1Of population,a
R67 T131 T132 arg1Of population,that
R68 T131 T133 arg1Of population,is
R69 T131 T134 arg2Of population,associated
R70 T134 T133 arg2Of associated,is
R71 T134 T135 arg1Of associated,with
R72 T134 T137 arg1Of associated,in
R73 T136 T135 arg2Of transformation,with
R74 T139 T137 arg2Of mice,in
R75 T139 T138 arg1Of mice,older
R76 T142 T140 arg1Of cells,The
R77 T142 T141 arg1Of cells,lymphoma
R78 T142 T143 arg1Of cells,have
R79 T142 T144 arg1Of cells,deregulated
R80 T144 T143 arg2Of deregulated,have
R81 T144 T149 arg1Of deregulated,and
R82 T147 T144 arg2Of markers,deregulated
R83 T147 T145 arg1Of markers,cell
R84 T147 T146 arg1Of markers,cycle
R85 T149 T148 arg1Of and,","
R86 T150 T151 arg1Of inhibitors,of
R87 T150 T158 arg1Of inhibitors,block
R88 T152 T153 arg1Of Akt,","
R89 T153 T156 arg1Of ",",and
R90 T154 T153 arg2Of NFκB,","
R91 T156 T151 arg2Of and,of
R92 T156 T155 arg1Of and,","
R93 T157 T156 arg2Of Stat3,and
R94 T158 T149 arg2Of block,and
R95 T158 T170 arg1Of block,vitro
R96 T161 T158 arg2Of viability,block
R97 T161 T159 arg1Of viability,the
R98 T161 T160 arg2Of viability,enhanced
R99 T161 T162 arg1Of viability,of
R100 T165 T163 arg1Of lymphocytes,LMP1
R101 T165 T164 arg1Of lymphocytes,transgenic
R102 T165 T166 arg1Of lymphocytes,and
R103 T166 T162 arg2Of and,of
R104 T168 T166 arg2Of cells,and
R105 T168 T167 arg1Of cells,lymphoma
R106 T170 T169 arg1Of vitro,in
R107 T172 T171 arg1Of cells,Lymphoma
R108 T172 T173 arg1Of cells,are
R109 T172 T174 arg1Of cells,independent
R110 T172 T184 arg1Of cells,have
R111 T172 T186 arg1Of cells,activated
R112 T173 T183 arg1Of are,but
R113 T174 T173 arg2Of independent,are
R114 T174 T175 arg1Of independent,of
R115 T177 T175 arg2Of signaling,of
R116 T177 T176 arg1Of signaling,IL4/Stat6
R117 T177 T178 arg1Of signaling,for
R118 T179 T180 arg1Of survival,and
R119 T180 T178 arg2Of and,for
R120 T181 T180 arg2Of proliferation,and
R121 T183 T182 arg1Of but,","
R122 T186 T183 arg2Of activated,but
R123 T186 T184 arg2Of activated,have
R124 T186 T185 arg1Of activated,constitutively
R125 T188 T186 arg2Of signaling,activated
R126 T188 T187 arg1Of signaling,Stat3
R127 T191 T189 arg1Of targets,These
R128 T191 T190 arg1Of targets,same
R129 T191 T192 arg1Of targets,are
R130 T191 T194 arg2Of targets,deregulated
R131 T194 T192 arg2Of deregulated,are
R132 T194 T193 arg1Of deregulated,also
R133 T194 T195 arg1Of deregulated,in
R134 T198 T195 arg2Of lymphomas,in
R135 T198 T196 arg1Of lymphomas,wild-type
R136 T198 T197 arg1Of lymphomas,B-1a
R137 T198 T199 arg1Of lymphomas,that
R138 T198 T200 arg1Of lymphomas,arise
R139 T200 T201 arg1Of arise,spontaneously
R140 T200 T202 arg1Of arise,through
R141 T204 T202 arg2Of predisposition,through
R142 T204 T203 arg1Of predisposition,age
R143 T206 T205 arg1Of results,These
R144 T206 T207 arg1Of results,suggest
R145 T209 T210 arg1Of Akt,","
R146 T210 T213 arg1Of ",",and
R147 T211 T210 arg2Of NFκB,","
R148 T213 T212 arg1Of and,","
R149 T213 T216 arg1Of and,may
R150 T213 T217 arg1Of and,serve
R151 T215 T213 arg2Of pathways,and
R152 T215 T214 arg1Of pathways,Stat3
R153 T217 T207 arg2Of serve,suggest
R154 T217 T208 arg1Of serve,that
R155 T217 T216 arg2Of serve,may
R156 T217 T218 arg1Of serve,as
R157 T220 T218 arg2Of targets,as
R158 T220 T219 arg1Of targets,effective
R159 T220 T221 arg1Of targets,in
R160 T223 T221 arg2Of treatment,in
R161 T223 T222 arg1Of treatment,the
R162 T223 T224 arg1Of treatment,of
R163 T228 T224 arg2Of lymphomas,of
R164 T228 T225 arg1Of lymphomas,EBV-associated
R165 T228 T226 arg1Of lymphomas,B
R166 T228 T227 arg1Of lymphomas,cell

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T229 620-638 Anaphor denotes These same targets
T230 517-520 Antecedent denotes IL4
T231 521-526 Antecedent denotes Stat6
T232 603-608 Antecedent denotes Stat3
R355 T229 T230 boundBy These same targets,IL4
R356 T229 T231 boundBy These same targets,Stat6
R357 T229 T232 boundBy These same targets,Stat3

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T269 0-6 NNP denotes Latent
T270 7-15 NN denotes membrane
T271 16-23 NN denotes protein
T272 24-25 CD denotes 1
T273 26-27 -LRB- denotes (
T274 27-31 CD denotes LMP1
T275 31-32 -RRB- denotes )
T276 33-35 VBZ denotes is
T277 36-39 DT denotes the
T278 40-45 JJ denotes major
T279 46-57 NN denotes oncoprotein
T280 58-60 IN denotes of
T281 61-73 NNP denotes Epstein-Barr
T282 74-79 NN denotes virus
T283 80-81 -LRB- denotes (
T284 81-84 NNP denotes EBV
T285 84-85 -RRB- denotes )
T286 85-86 . denotes .
T287 87-89 IN denotes In
T288 90-100 JJ denotes transgenic
T289 101-105 NNS denotes mice
T290 105-106 , denotes ,
T291 107-111 NNP denotes LMP1
T292 112-120 VBZ denotes promotes
T293 121-130 VBN denotes increased
T294 131-139 NN denotes lymphoma
T295 140-151 NN denotes development
T296 152-154 IN denotes by
T297 155-157 CD denotes 12
T298 158-160 NN denotes mo
T299 161-163 IN denotes of
T300 164-167 NN denotes age
T301 167-168 . denotes .
T302 169-173 DT denotes This
T303 174-179 NN denotes study
T304 180-187 VBZ denotes reveals
T305 188-192 IN denotes that
T306 193-201 NN denotes lymphoma
T307 202-210 VBZ denotes develops
T308 211-213 IN denotes in
T309 214-218 NN denotes B-1a
T310 219-230 NNS denotes lymphocytes
T311 230-231 , denotes ,
T312 232-233 DT denotes a
T313 234-244 NN denotes population
T314 245-249 WDT denotes that
T315 250-252 VBZ denotes is
T316 253-263 VBN denotes associated
T317 264-268 IN denotes with
T318 269-283 NN denotes transformation
T319 284-286 IN denotes in
T320 287-292 JJR denotes older
T321 293-297 NNS denotes mice
T322 297-298 . denotes .
T323 299-302 DT denotes The
T324 303-311 NN denotes lymphoma
T325 312-317 NNS denotes cells
T326 318-322 VBP denotes have
T327 323-334 VBN denotes deregulated
T328 335-339 NN denotes cell
T329 340-345 NN denotes cycle
T330 346-353 NNS denotes markers
T331 353-354 , denotes ,
T332 355-358 CC denotes and
T333 359-369 NNS denotes inhibitors
T334 370-372 IN denotes of
T335 373-376 NNP denotes Akt
T336 376-377 , denotes ,
T337 378-382 NNP denotes NFκB
T338 382-383 , denotes ,
T339 384-387 CC denotes and
T340 388-393 JJ denotes Stat3
T341 394-399 NN denotes block
T342 400-403 DT denotes the
T343 404-412 JJ denotes enhanced
T344 413-422 NN denotes viability
T345 423-425 IN denotes of
T346 426-430 CD denotes LMP1
T347 431-441 JJ denotes transgenic
T348 442-453 NNS denotes lymphocytes
T349 454-457 CC denotes and
T350 458-466 NN denotes lymphoma
T351 467-472 NNS denotes cells
T352 473-475 IN denotes in
T353 476-481 NN denotes vitro
T354 481-482 . denotes .
T355 483-491 NNP denotes Lymphoma
T356 492-497 NNS denotes cells
T357 498-501 VBP denotes are
T358 502-513 JJ denotes independent
T359 514-516 IN denotes of
T360 517-526 NNP denotes IL4/Stat6
T361 527-536 VBG denotes signaling
T362 537-540 IN denotes for
T363 541-549 NN denotes survival
T364 550-553 CC denotes and
T365 554-567 NN denotes proliferation
T366 567-568 , denotes ,
T367 569-572 CC denotes but
T368 573-577 VBP denotes have
T369 578-592 RB denotes constitutively
T370 593-602 VBN denotes activated
T371 603-608 JJ denotes Stat3
T372 609-618 VBG denotes signaling
T373 618-619 . denotes .
T374 620-625 DT denotes These
T375 626-630 JJ denotes same
T376 631-638 NNS denotes targets
T377 639-642 VBP denotes are
T378 643-647 RB denotes also
T379 648-659 VBN denotes deregulated
T380 660-662 IN denotes in
T381 663-672 JJ denotes wild-type
T382 673-677 NN denotes B-1a
T383 678-687 NNS denotes lymphomas
T384 688-692 WDT denotes that
T385 693-698 VBP denotes arise
T386 699-712 RB denotes spontaneously
T387 713-720 IN denotes through
T388 721-724 NN denotes age
T389 725-739 NN denotes predisposition
T390 739-740 . denotes .
T391 741-746 DT denotes These
T392 747-754 NNS denotes results
T393 755-762 VBP denotes suggest
T394 763-767 IN denotes that
T395 768-771 NNP denotes Akt
T396 771-772 , denotes ,
T397 773-777 NNP denotes NFκB
T398 777-778 , denotes ,
T399 779-782 CC denotes and
T400 783-788 JJ denotes Stat3
T401 789-797 NNS denotes pathways
T402 798-801 MD denotes may
T403 802-807 VB denotes serve
T404 808-810 IN denotes as
T405 811-820 JJ denotes effective
T406 821-828 NNS denotes targets
T407 829-831 IN denotes in
T408 832-835 DT denotes the
T409 836-845 NN denotes treatment
T410 846-848 IN denotes of
T411 849-863 JJ denotes EBV-associated
T412 864-865 NNP denotes B
T413 866-870 NN denotes cell
T414 871-880 NNS denotes lymphomas
T415 880-881 . denotes .
R187 T275 T271 punct ),protein
R188 T276 T276 ROOT is,is
R189 T277 T279 det the,oncoprotein
R190 T278 T279 amod major,oncoprotein
R191 T279 T276 attr oncoprotein,is
R192 T280 T279 prep of,oncoprotein
R193 T281 T282 compound Epstein-Barr,virus
R194 T282 T280 pobj virus,of
R195 T283 T284 punct (,EBV
R196 T284 T282 appos EBV,virus
R197 T285 T279 punct ),oncoprotein
R198 T286 T276 punct .,is
R199 T287 T292 prep In,promotes
R200 T288 T289 amod transgenic,mice
R201 T289 T287 pobj mice,In
R202 T290 T292 punct ",",promotes
R203 T291 T292 nsubj LMP1,promotes
R204 T292 T292 ROOT promotes,promotes
R205 T293 T295 amod increased,development
R206 T294 T295 compound lymphoma,development
R207 T295 T292 dobj development,promotes
R208 T296 T292 prep by,promotes
R209 T297 T298 nummod 12,mo
R210 T298 T296 pobj mo,by
R211 T299 T298 prep of,mo
R212 T300 T299 pobj age,of
R213 T301 T292 punct .,promotes
R214 T302 T303 det This,study
R215 T303 T304 nsubj study,reveals
R216 T304 T304 ROOT reveals,reveals
R217 T305 T307 mark that,develops
R218 T306 T307 nsubj lymphoma,develops
R219 T307 T304 ccomp develops,reveals
R220 T308 T307 prep in,develops
R221 T309 T310 compound B-1a,lymphocytes
R222 T310 T308 pobj lymphocytes,in
R223 T311 T307 punct ",",develops
R224 T312 T313 det a,population
R225 T313 T307 dobj population,develops
R226 T314 T316 nsubjpass that,associated
R227 T315 T316 auxpass is,associated
R228 T316 T313 relcl associated,population
R229 T317 T316 prep with,associated
R230 T318 T317 pobj transformation,with
R231 T319 T318 prep in,transformation
R232 T320 T321 amod older,mice
R233 T321 T319 pobj mice,in
R234 T322 T304 punct .,reveals
R235 T323 T325 det The,cells
R236 T324 T325 compound lymphoma,cells
R237 T325 T327 nsubj cells,deregulated
R238 T326 T327 aux have,deregulated
R239 T327 T327 ROOT deregulated,deregulated
R240 T328 T329 compound cell,cycle
R241 T329 T330 compound cycle,markers
R242 T330 T327 dobj markers,deregulated
R243 T331 T330 punct ",",markers
R244 T332 T330 cc and,markers
R245 T333 T330 conj inhibitors,markers
R246 T334 T330 prep of,markers
R247 T335 T334 pobj Akt,of
R248 T336 T335 punct ",",Akt
R249 T337 T335 conj NFκB,Akt
R250 T338 T337 punct ",",NFκB
R251 T339 T337 cc and,NFκB
R252 T340 T341 amod Stat3,block
R253 T341 T330 appos block,markers
R254 T342 T344 det the,viability
R255 T343 T344 amod enhanced,viability
R256 T344 T341 dobj viability,block
R257 T345 T344 prep of,viability
R258 T346 T348 nummod LMP1,lymphocytes
R259 T347 T348 amod transgenic,lymphocytes
R260 T348 T345 pobj lymphocytes,of
R261 T349 T348 cc and,lymphocytes
R262 T350 T351 compound lymphoma,cells
R263 T351 T348 conj cells,lymphocytes
R264 T352 T344 prep in,viability
R265 T353 T352 pobj vitro,in
R266 T354 T327 punct .,deregulated
R267 T355 T356 compound Lymphoma,cells
R268 T356 T357 nsubj cells,are
R269 T357 T357 ROOT are,are
R270 T358 T357 acomp independent,are
R271 T359 T358 prep of,independent
R272 T360 T359 pobj IL4/Stat6,of
R273 T361 T357 advcl signaling,are
R274 T362 T361 prep for,signaling
R275 T363 T362 pobj survival,for
R276 T364 T363 cc and,survival
R277 T365 T363 conj proliferation,survival
R278 T366 T357 punct ",",are
R279 T367 T357 cc but,are
R280 T368 T370 aux have,activated
R281 T369 T370 advmod constitutively,activated
R282 T370 T357 conj activated,are
R283 T371 T372 amod Stat3,signaling
R284 T372 T370 dobj signaling,activated
R285 T373 T357 punct .,are
R286 T374 T376 det These,targets
R287 T375 T376 amod same,targets
R288 T376 T379 nsubjpass targets,deregulated
R289 T377 T379 auxpass are,deregulated
R290 T378 T379 advmod also,deregulated
R291 T379 T379 ROOT deregulated,deregulated
R292 T380 T379 prep in,deregulated
R293 T381 T383 amod wild-type,lymphomas
R294 T382 T383 compound B-1a,lymphomas
R295 T383 T380 pobj lymphomas,in
R296 T384 T385 nsubj that,arise
R297 T385 T383 relcl arise,lymphomas
R298 T386 T385 advmod spontaneously,arise
R299 T387 T385 prep through,arise
R300 T388 T389 compound age,predisposition
R301 T389 T387 pobj predisposition,through
R302 T390 T379 punct .,deregulated
R303 T391 T392 det These,results
R304 T392 T393 nsubj results,suggest
R305 T393 T393 ROOT suggest,suggest
R306 T394 T403 mark that,serve
R307 T395 T403 nsubj Akt,serve
R308 T396 T395 punct ",",Akt
R309 T397 T395 conj NFκB,Akt
R310 T398 T397 punct ",",NFκB
R311 T399 T397 cc and,NFκB
R312 T400 T401 amod Stat3,pathways
R313 T401 T397 conj pathways,NFκB
R314 T402 T403 aux may,serve
R315 T403 T393 ccomp serve,suggest
R316 T404 T403 prep as,serve
R317 T405 T406 amod effective,targets
R318 T406 T404 pobj targets,as
R319 T407 T406 prep in,targets
R320 T408 T409 det the,treatment
R321 T409 T407 pobj treatment,in
R322 T410 T409 prep of,treatment
R323 T411 T414 amod EBV-associated,lymphomas
R324 T412 T413 compound B,cell
R325 T413 T414 compound cell,lymphomas
R326 T414 T410 pobj lymphomas,of
R327 T415 T393 punct .,suggest
R181 T269 T271 compound Latent,protein
R182 T270 T271 compound membrane,protein
R184 T272 T271 nummod 1,protein
R185 T273 T271 punct (,protein
R186 T274 T271 appos LMP1,protein

GO-BP

Id Subject Object Predicate Lexical cue
T67 140-151 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T68 164-167 http://purl.obolibrary.org/obo/GO_0007568 denotes age
T69 721-724 http://purl.obolibrary.org/obo/GO_0007568 denotes age
T70 335-345 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T71 527-536 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T72 609-618 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

GO-CC

Id Subject Object Predicate Lexical cue
T425 7-15 http://purl.obolibrary.org/obo/GO_0016020 denotes membrane
T426 312-317 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T427 467-472 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T428 492-497 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T429 866-870 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T60 0-86 Sentence denotes Latent membrane protein 1 (LMP1) is the major oncoprotein of Epstein-Barr virus (EBV).
T61 87-168 Sentence denotes In transgenic mice, LMP1 promotes increased lymphoma development by 12 mo of age.
T62 169-298 Sentence denotes This study reveals that lymphoma develops in B-1a lymphocytes, a population that is associated with transformation in older mice.
T63 299-482 Sentence denotes The lymphoma cells have deregulated cell cycle markers, and inhibitors of Akt, NFκB, and Stat3 block the enhanced viability of LMP1 transgenic lymphocytes and lymphoma cells in vitro.
T64 483-619 Sentence denotes Lymphoma cells are independent of IL4/Stat6 signaling for survival and proliferation, but have constitutively activated Stat3 signaling.
T65 620-740 Sentence denotes These same targets are also deregulated in wild-type B-1a lymphomas that arise spontaneously through age predisposition.
T66 741-881 Sentence denotes These results suggest that Akt, NFκB, and Stat3 pathways may serve as effective targets in the treatment of EBV-associated B cell lymphomas.
T3 0-86 Sentence denotes Latent membrane protein 1 (LMP1) is the major oncoprotein of Epstein-Barr virus (EBV).
T4 87-168 Sentence denotes In transgenic mice, LMP1 promotes increased lymphoma development by 12 mo of age.
T5 169-298 Sentence denotes This study reveals that lymphoma develops in B-1a lymphocytes, a population that is associated with transformation in older mice.
T6 299-482 Sentence denotes The lymphoma cells have deregulated cell cycle markers, and inhibitors of Akt, NFκB, and Stat3 block the enhanced viability of LMP1 transgenic lymphocytes and lymphoma cells in vitro.
T7 483-619 Sentence denotes Lymphoma cells are independent of IL4/Stat6 signaling for survival and proliferation, but have constitutively activated Stat3 signaling.
T8 620-740 Sentence denotes These same targets are also deregulated in wild-type B-1a lymphomas that arise spontaneously through age predisposition.
T9 741-881 Sentence denotes These results suggest that Akt, NFκB, and Stat3 pathways may serve as effective targets in the treatment of EBV-associated B cell lymphomas.

events-check-again

Id Subject Object Predicate Lexical cue Negation
T500 0-25 Protein denotes Latent membrane protein 1
T501 27-31 Protein denotes LMP1
T502 107-111 Protein denotes LMP1
T503 359-369 Negative_regulation denotes inhibitors
T504 359-369 Negative_regulation denotes inhibitors
T505 373-376 Protein denotes Akt
T506 388-393 Protein denotes Stat3
T507 426-430 Protein denotes LMP1
T508 517-520 Protein denotes IL4
T509 521-526 Protein denotes Stat6
T510 603-608 Protein denotes Stat3
T511 648-659 Regulation denotes deregulated true
T512 648-659 Regulation denotes deregulated true
T513 648-659 Regulation denotes deregulated true
T514 768-771 Protein denotes Akt
T515 783-788 Protein denotes Stat3
R373 T505 T504 themeOf Akt,inhibitors
R374 T506 T503 themeOf Stat3,inhibitors
R375 T508 T513 themeOf IL4,deregulated
R376 T509 T511 themeOf Stat6,deregulated
R377 T510 T512 themeOf Stat3,deregulated

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T479 0-25 Protein denotes Latent membrane protein 1
T480 27-31 Protein denotes LMP1
T481 107-111 Protein denotes LMP1
T482 373-376 Protein denotes Akt
T483 378-382 Protein denotes NFκB
T484 388-393 Protein denotes Stat3
T485 426-430 Protein denotes LMP1
T486 359-369 Negative_regulation denotes inhibitors
T487 359-369 Negative_regulation denotes inhibitors
T488 359-369 Negative_regulation denotes inhibitors
T489 517-520 Protein denotes IL4
T490 521-526 Protein denotes Stat6
T491 603-608 Protein denotes Stat3
T492 768-771 Protein denotes Akt
T493 773-777 Protein denotes NFκB
T494 783-788 Protein denotes Stat3
R343 T482 T486 themeOf Akt,inhibitors
R344 T483 T487 themeOf NFκB,inhibitors
R345 T484 T488 themeOf Stat3,inhibitors

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation
T57 768-771 Protein denotes Akt
T58 783-788 Protein denotes Stat3
T43 0-25 Protein denotes Latent membrane protein 1
T44 27-31 Protein denotes LMP1
T45 107-111 Protein denotes LMP1
T46 359-369 Negative_regulation denotes inhibitors
T47 359-369 Negative_regulation denotes inhibitors
T48 373-376 Protein denotes Akt
T49 388-393 Protein denotes Stat3
T50 426-430 Protein denotes LMP1
T51 517-520 Protein denotes IL4
T52 521-526 Protein denotes Stat6
T53 603-608 Protein denotes Stat3
T54 648-659 Regulation denotes deregulated true
T55 648-659 Regulation denotes deregulated true
T56 648-659 Regulation denotes deregulated true
R350 T48 T47 themeOf Akt,inhibitors
R351 T49 T46 themeOf Stat3,inhibitors
R352 T51 T56 themeOf IL4,deregulated
R353 T52 T54 themeOf Stat6,deregulated
R354 T53 T55 themeOf Stat3,deregulated

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T249 768-771 P31749 denotes Akt
T250 768-771 P31751 denotes Akt
T251 768-771 Q9Y243 denotes Akt
T252 783-788 P40763 denotes Stat3
T238 0-25 P03230 denotes Latent membrane protein 1
T239 27-31 P03230 denotes LMP1
T240 107-111 P03230 denotes LMP1
T241 373-376 Q9Y243 denotes Akt
T242 373-376 P31751 denotes Akt
T243 373-376 P31749 denotes Akt
T244 388-393 P40763 denotes Stat3
T245 426-430 P03230 denotes LMP1
T246 517-520 P05112 denotes IL4
T247 521-526 P42226 denotes Stat6
T248 603-608 P40763 denotes Stat3

test2

Id Subject Object Predicate Lexical cue Negation
T26 0-25 Protein denotes Latent membrane protein 1 true
T27 27-31 Protein denotes LMP1 true
T28 107-111 Protein denotes LMP1 true
T29 373-376 Protein denotes Akt
T30 388-393 Protein denotes Stat3
T31 426-430 Protein denotes LMP1
T32 517-520 Protein denotes IL4
T33 521-526 Protein denotes Stat6
T34 593-602 Positive_regulation denotes activated
T35 603-608 Protein denotes Stat3
T36 768-771 Protein denotes Akt
T37 783-788 Protein denotes Stat3
R11 T27 T26 equivalentTo LMP1,Latent membrane protein 1